Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with Ramipril and vitamin E: SECURE

American Journal of Cardiology

Volumn 78, Issue 8, 1996, Pages 914-919

  Lonn, E M ^b   Yusuf, S ^a   Doris, C I ^b   Sabine, M J ^b   Dzavik, V ^b   Hutchison, K ^b   Riley, W A ^b   Tucker, J ^b   Pogue, J ^b   Taylor, W ^b  

^a HAMILTON GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

AGED; ARTERIOSCLEROSIS; ARTICLE; BRAIN ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; HUMAN; MALE; METHODOLOGY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIOSCLEROSIS; CAROTID ARTERY DISEASES; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; RAMIPRIL; RESEARCH DESIGN; RISK FACTORS; VITAMIN E;

EID: 10644263761     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00467-5     Document Type: Article

References (28)

1. American Heart Association. 1993 Heart and Stroke Facts Statistics. Dallas, TX: American Heart Association; 1993:2-16.
2. HOPE Study Investigators. The HOPE (Heart Outcomes Prevention Evalu-ation) study: the design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1996;12:127-137.
3. Lonn EM, Yusuf S, Prabhat J, Montague TJ, Koon KT, Benedict CR, Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994;90:2056-2069.
4. Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173-1178.
5. Rutherford JD, Pfeffer MA, Moyé LA, Davis BR, Flaker GC, Kowey PR, Lamas GA, Miller HS, Packer M, Rouleau JL, Braunwald E, on behalf of the SAVE Investigators. Effects of captopril on ischemic events after myocardial infarction: results of the Survival And Ventricular Enlargement trial. Circulation 1994;90:1731-1738.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum J. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
7. Wojciki J, Roziwat A, Batcew-Wisziewska B. Effect of selenium and vitamin E on development of experimental atherosclerosis in rabbits. Atherosclerosis 1991;87:9-16.
8. Jandak JM, Steiner M, Richardson PD. Reduction of platelet adhesiveness by vitamin E supplementation in humans. Thrombos Res 1988;49:393-404.
9. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53:326S-334S.
10. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-1449.
11. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456.
12. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995;123:860-872.
13. ACAPS Group. Rationale and design for the asymptomatic carotid artery plaque study (ACAPS). Control Clin Trials 1992;13:293-314.
14. Crouse JR, Byington RP, Bard MG, Espeland MA, Sprinkle JW, McGovern M, Furberg CD. Pravastatin, lipids, and atherosclerosis in carotid arteries. Design features of a clinical trial with carotid atherosclerosis outcome. Control Clin Trials 1992;13:495-506.
15. Furberg CD, Adams HP, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lef kowitz DS, Probstfield J, Riley WA, Young B, for the Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994;90:1679-1687.
16. Bond MG, Barnes RW, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B. High-resolution B-mode ultrasound scanning methods in the atherosclerosis risk in communities study (ARIC). J Neuroimag 1991;1:68-73.
17. O'Leary D, Polak JF, Wolfson SK, Bond GM, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA, on behalf of the CHS Collaborative Research Group. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. Stroke 1991;22:1155-1163.
18. Borhani NO, Brugger SB, Byington RP. Multicenter study with isradipine and diuretics against atherosclerosis. J Cardiovasc Pharmocol 1990;15(suppl I):S23-S29.
19. Salonen R, Nyyssönen K, Porkkala-Sarataho E, Salonen JT. The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerosis progression. Am J Cardiol 1995;76:34C-39C.
20. Mercuri M. Noninvasive imaging protocols to detect and monitor carotid atherosclerosis progression. Am J Hypertens 1994;7:23S-29S.
21. Riley WA, Barnes RW, Applegate WB, Dempsey R, Hartwell T, Davis VG, Bond G. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Stroke 1992;23:1-7.
22. Mercuri M, Bond MG, Nichols FT, Carr AA, Flack JM, Byington R, for the MIDAS group. Baseline reproducibility of B-mode ultrasound imaging measurements of carotid intima-media thickness: the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). J Cardiovasc Diagn Proc 1993;11:241-256.
23. Furberg CD, Byington RP, Riley W. B-mode ultrasound: a noninvasive method for assessing atherosclerosis. Cardiovasc Med 1994;1182-1187.
24. Crouse JR, Craven TE, Hegeman AP, Bond MG. Association of coronary disease with segment-specific intimal-medial thickening of extracranial carotid artery. Circulation 1995;92:1141-1147.
25. Margitic SE, Bond MG, Crouse JR, Furberg CD, Probstfield JL. Progression and regression of carotid atherosclerosis in clinical trials. Arterioscler Thrombos 1991;11:443-451.
26. Salonen R, Salonen KT. Progression of carotid atherosclerosis and its determinants: a population based study. Atherosclerosis 1990;81:33-40.
27. Buyington RP, Furberg CD, Crouse JR, Espeland MA, Bond G. Pravastatin, lipids and atherosclerosis in carotid arteries (PLAC-II). Am J Cardiol 1995;76:54C-59C.
28. Espeland MA, Byington RP, Hire D, Davis VG, Hartwell T, Probstfield J. Analysis strategies for serial multivariate ultrasonographic data that are incomplete. Statist Med 1991;11:1041-1056.